Related Articles
Cisplatin‑resistant germ cell tumor models: An exploration of the epithelial‑mesenchymal transition regulator <em>SLUG</em>
Repression of cyclin D1 as a target for germ cell tumors
VEGF‑C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin
Pharmacological ascorbate induces ‘BRCAness’ and enhances the effects of Poly(ADP‑Ribose) polymerase inhibitors against BRCA1/2 wild‑type ovarian cancer
Effects of primary granulocyte‑colony stimulating factor prophylaxis on the incidence of febrile neutropenia in patients with germ cell tumors